Anticipated cash depletion by end of 2022
Company: Core Scientific
What the later record shows
Outcome not yet confirmed
This was a forecast, not a commitment. The 10-K shows $15.9M of cash and equivalents at December 31, 2022, after the December 21, 2022 Chapter 11 filing. The passages do not settle whether the pre-existing cash was depleted.
“Cash and cash equivalents $ 836,197 $ 50,409 $ 15,884 Restricted cash 783 19,300 36,356”
2025-02-26 · Core Scientific 10-K filed 2025-02-27 View cached copy (2026-08-31)Live source ↗
Checked October 10, 2026 against filings, releases and reporting published after the claim was made. Quotes are verbatim from the linked documents.
The claim, verbatim
The Company anticipates that existing cash resources will be depleted by the end of 2022 or sooner.
Source (primary)
Core Scientific 8-K filed 2022-10-27 (SEC EDGAR, sec_filing)
View cached copy (2026-09-13)Live source ↗
Quote: “The Company anticipates that existing cash resources will be depleted by the end of 2022 or sooner.”
How we checked this
Checked on October 11, 2026. The cited source supports every part of this claim.
The 8-K states this expectation word for word.
Confirmed in the source:
- Core Scientific anticipated that its existing cash resources would be depleted by the end of 2022 or sooner
What we did: Read our cached copy of SEC EDGAR (https://www.sec.gov/Archives/edgar/data/1839341/000119312522270236/d395956d8k.htm) in full (13,474 characters, retrieved September 13, 2026) and checked each assertion in the claim against it.
Additional evidence
confirms Core Scientific 8-K filed 2022-10-27
Quote: “The Company anticipates that existing cash resources will be depleted by the end of 2022 or sooner.”